Homeo AI vs CuraVis: Offline Practice or Review Copilot?

Quick answer

Choose CuraVis when the tested job is keeping a homeopathy practice's patients, detailed case-taking, appointments, prescriptions, follow-ups, vital signs, laboratory results, and reference material in an encrypted offline-first system. Choose Homeo AI when the tested job begins with a completed case narrative and requires a practitioner to inspect proposed symptoms, rubric mappings, source passages, remedy differences, corrections, and follow-up changes before accepting an interpretation.

CuraVis is presented as a practice and clinical-record system built for homeopathy doctors in India. Homeo AI is a case-review copilot. CuraVis's genuine distinction is local-first continuity plus operational records. Homeo AI's comparison value is a narrower, reconstructable path from ordinary language to practitioner-reviewed analysis. A clinic could use both, but only after deciding which system is authoritative and which information may cross the boundary.

This review uses CuraVis's live product, pricing, privacy, terms, and security pages as captured on 15 August 2026. They are current first-party sources controlled by the vendor. They describe the public offer and its safeguards, but they do not independently validate launch status, app-store availability, security implementation, legal compliance, source quality, clinical accuracy, adoption, uptime, or outcomes.

What is current in CuraVis

CuraVis describes an offline-first application for patient records, appointments, prescriptions, follow-ups, vital signs, laboratory reports, documents, photographs, and homeopathic case-taking. The vendor says an encrypted database remains on the practitioner's device and synchronises when connectivity returns. Its public pricing page currently lists access on iPhone, iPad, Android, Mac, and web, unlimited patients and visits, full library packs, regular updates, and one assistant account.

The assistant boundary is unusually specific. CuraVis says an assistant may manage the patient directory and calendar but cannot see case notes, prescriptions, or attachments. That is a useful design claim for a clinic that needs front-desk help without broad clinical access. It still needs a hands-on test. Verify whether search results, notifications, exports, cached pages, appointment reasons, audit logs, and support tools reveal more than the role description implies. Also test immediate revocation and what happens to an assistant's device after access is removed.

The public product surfaces currently disagree about release maturity. The pricing page says the applications are available across mobile, desktop, and web, while other first-party text still uses early-access or coming-to-store language. This may reflect an ordinary staged rollout or an older marketing section, but a buyer should not infer availability. Ask the vendor to identify the production application, supported operating-system versions, onboarding route, app-store publisher, current release number, update policy, offline limits, and support channel in writing.

Pricing is negotiated, so define the complete offer

CuraVis advertises one complete plan rather than several public feature tiers. The current page says the plan includes unlimited patients and visits, all advertised clinical modules, the full library packs, updates, and one assistant. It does not publish a numeric price. The page invites a practice to contact the vendor for an offer.

A negotiated price is not inherently a drawback, but it makes offer definition essential. Ask for the currency, tax, billing period, practitioner seats, assistant seats, device count, storage, sync allowance, support hours, implementation, data migration, library licences, updates, renewal cap, cancellation, refunds, export assistance, and post-cancellation access in the same order document. Confirm whether unlimited patients includes archived and imported records and whether image or document storage has a separate ceiling.

The terms say plan details and prices are communicated in advance and may change. Save the signed order, pricing snapshot, and applicable terms together. Confirm which document controls if the public page and order disagree. Also ask whether offline access continues when a subscription expires, which features require an active server connection, and how long the clinic can export records after cancellation.

Privacy, AI, and processor questions

CuraVis's privacy policy is marked version 1.2 and effective 27 July 2026. It distinguishes the practitioner as Data Fiduciary for patient records and CuraVis as a processor acting on the practitioner's instructions. It says core records are stored in an encrypted local database and synchronised through protected connections, with server-side encryption and account-scoped access.

The policy also describes an optional AI-assistance feature. It says text or images submitted to that feature may be sent to a model provider under terms that prohibit retention or training and that the feature can be disabled. Those are meaningful boundaries to examine, but they do not tell a clinic exactly which fields leave the device. Before enabling AI, ask for the provider and region, subprocessor list, request and response logging, redaction behavior, retry storage, support access, deletion timing, model-change notice, and a contractual statement covering training and retention.

The policy refers to Indian data-protection duties and operational retention, while the security page describes encryption, authentication, access controls, backups, monitoring, and incident handling. It also refers to three-year clinical-record retention and 180-day security-log retention. Confirm which obligations apply to the practitioner's jurisdiction and record type, who can restore a backup, how deletion propagates, whether local copies remain on lost devices, and what proof the vendor can provide for each technical claim. A control list is useful diligence input, not an independent audit.

Where Homeo AI fits

Homeo AI should be judged on a different primary job. It starts with a completed practitioner narrative, proposes a structured symptom view and rubric mappings, lets the practitioner accept or reject transformations, exposes supporting material, compares remedies, and preserves a review trail into follow-up. Its usefulness depends on whether the reasoning can be reconstructed and corrected, not on whether it stores every operational record.

Homeo AI does not replace CuraVis's advertised offline patient database, calendar, assistant role, prescriptions, vital signs, laboratory records, attachments, or device synchronisation. CuraVis should not be assumed to reproduce Homeo AI's exact narrative-to-rubric correction path merely because it supports detailed case-taking, reference libraries, and optional AI assistance.

If a clinic uses both, keep the boundary narrow. CuraVis may hold the authoritative patient record, appointment, documents, and final authorised prescription. Homeo AI may receive a de-identified completed narrative for analysis. Move only a practitioner-approved summary back into the record. Do not automatically replicate photographs, laboratory documents, or identifiers into an AI workflow, and do not create two editable master records.

A reproducible clinic test

Prepare four completed, de-identified cases: a detailed first consultation, a follow-up with changed modalities, a case containing a laboratory result, and a case with an attachment. Remove names, phone numbers, dates, addresses, document identifiers, faces, and rare contextual combinations before testing. Use invented appointments and prescriptions, not real patient care.

In CuraVis, test once online and once without connectivity. Create a patient and appointment, record the case, add a vital sign and test result, attach an invented document, draft a prescription, reconnect, and export the complete record. Have an assistant reschedule the appointment and attempt to view case notes, prescriptions, attachments, notifications, and search results. Revoke the assistant and check every active session. Edit a record on two devices before synchronisation and document how conflicts and duplicates are resolved.

Then test exit and recovery. Ask for a full export, inspect whether narrative, structured fields, prescriptions, attachments, audit history, and source identifiers are included, and determine whether another system can read them. Request the documented backup and restoration process. Do not intentionally erase the trial until the clinic understands whether deletion is reversible and which server, backup, and device copies remain.

In Homeo AI, use the same de-identified narratives. Record which symptoms and rubrics are proposed, accepted, edited, or rejected; which supporting passages are opened; whether a second practitioner can reconstruct the reasoning; and whether follow-up observations remain separate from baseline facts. For the laboratory case, verify that measured results are not silently turned into unsupported homeopathic interpretations.

Score both products on offline continuity, role isolation, correction clarity, source traceability, sync conflicts, export completeness, device recovery, cancellation access, data exposure, annual cost, and the time another practitioner needs to reconstruct a decision. A successful sync is not evidence that an analysis is correct. A readable differential is not proof that the underlying record is complete.

Known limits and clinical responsibility

CuraVis's availability, encryption, compliance, library, retention, assistant-role, offline, and AI-processing statements are vendor claims. This review did not independently validate its applications, local database, synchronisation, backups, source licences, processor contracts, security controls, or clinical results. The conflicting release-language surfaces and undisclosed price must remain procurement questions.

Homeo AI can also misread a narrative, omit context, map an unsuitable rubric, surface an irrelevant passage, or produce a plausible differential that needs correction. Inspectability enables review; it does not make output correct.

Neither product replaces diagnosis, referral, an emergency-care decision, practitioner judgment, prescription, potency, dosage, or follow-up responsibility. Urgent, severe, or rapidly worsening symptoms require appropriate medical assessment. The practitioner remains responsible for every accepted interpretation, source, record, prescription, and action.

Conditional verdict

Choose CuraVis if the clinic needs an offline-first homeopathy record with a deliberately restricted assistant role and a hands-on test confirms production availability, sync behavior, export, recovery, AI boundaries, and a complete written quote. Its local-first design is a real buying distinction if the clinic can verify it on every intended device.

Choose Homeo AI if the priority is a reconstructable review from the original narrative through practitioner-approved symptoms, rubrics, source inspection, remedy differentiation, and follow-up. If both products are used, establish one authoritative record, a de-identified review boundary, and a practitioner-approved one-way handoff before real patient information enters the workflow.

Official sources checked

• CuraVis official product page
• CuraVis official pricing page
• CuraVis privacy policy version 1.2
• CuraVis official terms
• CuraVis official security page

Product facts reviewed 2026-08-15. Confirm current features, prices, source libraries, and terms with the vendor.